Statin Reduced Risk of Heart Disease in People With HIV
By Ed Susman
The cholesterol-lowering agent pitavastatin (Livalo) as primary prevention reduced the risk of major adverse cardiovascular events (MACE) among people living with HIV, the randomized REPRIEVE trial showed.